Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 2,776 shares of the firm's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $12.34, for a total transaction of $34,255.84. Following the completion of the transaction, the director now directly owns 684,320 shares in the company, valued at approximately $8,444,508.80. The trade was a 0.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Saiyed Atiq Raza also recently made the following trade(s):
Shares of NASDAQ AIP remained flat at $11.25 during midday trading on Wednesday. The stock had a trading volume of 325,673 shares, compared to its average volume of 667,995. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The firm has a market cap of $451.99 million, a PE ratio of -11.72 and a beta of 1.17. The firm has a 50-day moving average price of $9.08 and a 200 day moving average price of $8.11. Arteris, Inc. has a 12-month low of $4.83 and a 12-month high of $12.64.
Hedge funds and other institutional investors have recently bought and sold shares of the business. US Bancorp DE bought a new stake in shares of Arteris during the 3rd quarter worth $34,000. The Manufacturers Life Insurance Company purchased a new stake in Arteris during the second quarter worth about $86,000. Algert Global LLC purchased a new stake in Arteris during the second quarter worth about $115,000. MetLife Investment Management LLC raised its position in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock worth $131,000 after acquiring an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Arteris in the third quarter valued at about $226,000. Hedge funds and other institutional investors own 64.36% of the company's stock.
Separately, Rosenblatt Securities reaffirmed a "buy" rating and set a $15.00 price objective on shares of Arteris in a report on Wednesday, November 6th.
Check Out Our Latest Research Report on AIP
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.